Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow MOH
Molina Healthcare, Inc (MOH) Piotroski F-score
Molina Healthcare, Inc's Piotroski F-score for fiscal 2025 is 4 out of 9: 4 of nine tests of profitability, leverage and efficiency passed, down from 5 in fiscal 2024.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2025 | 4 | (1.00) |
| FY2024 | 5 | (3.00) |
| FY2023 | 8 | 0.00 |
| FY2022 | 8 | 2.00 |
| FY2021 | 6 | 1.00 |
| FY2020 | 5 | 1.00 |
| FY2019 | 4 | (1.00) |
| FY2018 | 5 | 2.00 |
| FY2017 | 3 | (1.00) |
| FY2016 | 4 | — |
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | 3.03% | 7.73% | Pass | 1 |
| Positive operating cash flow | (535.00m) | 644.00m | Fail | 0 |
| Rising return on assets | 3.03% | 7.73% | Fail | 0 |
| Cash flow above net income | (1.01b) | (535.00m) | Fail | 0 |
| Falling long-term leverage | 0.25 | 0.20 | Fail | 0 |
| Rising current ratio | 1.69 | 1.62 | Pass | 1 |
| No new shares issued | 52,800,000 | 57,400,000 | Pass | 1 |
| Rising gross margin | 13.07% | 15.31% | Fail | 0 |
| Rising asset turnover | 2.91 | 2.66 | Pass | 1 |
| Piotroski F-score | Mixed | 4 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| PGNY Progyny, Inc. compare | 8 |
| CI Cigna Group compare | 8 |
| HUM Humana Inc. compare | 6 |
| ALHC Alignment Healthcare, Inc. compare | 6 |
| ELV Elevance Health, Inc. compare | 6 |
| CNC Centene Corporation compare | 5 |
| MOH Molina Healthcare, Inc | 4 |
| CLOV Clover Health Investments, Corp. compare | 3 |
| OSCR Oscar Health, Inc. compare | 3 |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover